Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Clémentine Joubert"'
Autor:
Cédric Rossi, Marc André, Jehan Dupuis, Franck Morschhauser, Bertrand Joly, Julien Lazarovici, Hervé Ghesquières, Aspasia Stamatoullas, Emmanuelle Nicolas-Virelizier, Pierre Feugier, Anne-Claire Gac, Hannah Moatti, Luc-Matthieu Fornecker, Bénédicte Deau, Clémentine Joubert, Catherine Fortpied, John Raemaekers, Massimo Federico, Salim Kanoun, Michel Meignan, Alexandra Traverse-Glehen, Anne-Ségolène Cottereau, René-Olivier Casasnova
Publikováno v:
Haematologica, Vol 107, Iss 12 (2022)
Stage IIB Hodgkin lymphoma (HL) patients, with a mediastinum-to-thorax (M/T) ratio of ≥0.33 or extranodal localization have a poor prognosis and are treated either as limited or advanced stage. We compared these two approaches in patients included
Externí odkaz:
https://doaj.org/article/3bfa108c1d994483b55ceb83af3e2524
Autor:
Aurélien Belot, Vincent Camus, Cédric Portugues, Jérome Paget, Loic Chartier, Pascale Cony‐Makhoul, Hervé Tilly, Clémentine Joubert
Publikováno v:
British Journal of Haematology. 201:857-864
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9678d72987096432b4fd920f5fb470e
https://doi.org/10.1111/bjh.18705
https://doi.org/10.1111/bjh.18705
Autor:
Vincent Camus, Aurélien Belot, Lucie Oberic, David Sibon, Hervé Ghesquières, Catherine Thieblemont, Christophe Fruchart, Olivier Casasnovas, Jean-Marie Michot, Thierry Jo Molina, André Bosly, Clémentine Joubert, Corinne Haioun, Emmanuelle Nicolas-Virelizier, Pierre Feugier, Olivier Fitoussi, Richard Delarue, Hervé Tilly
Publikováno v:
Blood Advances. 6:6169-6179
The LNH03-6B trial was a phase 3 randomized trial evaluating the efficacy of first-line rituximab, cyclophosphamide, doxorubicine, vincristine and prednisone (R-CHOP) delivered every 2 weeks (R-CHOP14) or 3 weeks (R-CHOP21) in patients with diffuse l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7069ad46fc2c733b31e08cbbb2c18dc2
https://doi.org/10.1182/bloodadvances.2022007609
https://doi.org/10.1182/bloodadvances.2022007609
Autor:
Steeve Chevreux, Sandra de Barros, Camille Laurent, Amandine Durand, Cyrille Delpierre, Philippine Robert, Clémentine Joubert, Samuel Griolet, Salim Kanoun, Jean-Noël Bastie, René-Olivier Casasnovas, Cédric Rossi
Publikováno v:
Cancers; Volume 15; Issue 1; Pages: 53
Introduction: Whereas numerous studies on several cancers describe the link between social conditions and disease severity, little is known about the social and demographic characteristics of Hodgkin lymphoma (HL) patients. At diagnosis, 10–15% of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdb007bee15636b1c16939008b3162c1
https://pubmed.ncbi.nlm.nih.gov/36612050
https://pubmed.ncbi.nlm.nih.gov/36612050
Autor:
Pauline Brice, Anne-Ségolène Cottereau, Anne-Claire Gac, Marc André, Catherine Fortpied, Massimo Federico, Julien Lazarovici, Cédric Rossi, René-Olivier Casasnovas, Sarah Bailly, Clémentine Joubert, Luc Mathieu Fornecker, Bénédicte Deau-Fisher, Salim Kanoun, Michel Meignan, Herve Ghesquieres, Marie Maerevoet, Aspasia Stamatoullas, John M.M. Raemakers
Publikováno v:
Blood. 134:128-128
Introduction High risk stage IIB Hodgkin lymphoma (HL) with mediastinum-to-thorax ratio of ≥0.33 or extranodal localization are defined as a poor prognosis subset according to German Hodgkin study group (Sieber et al., Ann. of Oncol. 2000). These p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc759a6ddbb257a0c952cbac0f7e8e4e
https://doi.org/10.1182/blood-2019-125976
https://doi.org/10.1182/blood-2019-125976